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Induction  of hapten-specific tolerance can be accomplished quite successfully in 
several different ways and has become a subject of increasing interest and analysis in 
recent years (reviewed in reference 1), because this model is one in which tolerance 
appears to be restricted to the B-cell population and, therefore, may be more ideally 
suited to elucidation of some of the cellular mechanisms involved in these inactivation 
processes. This is particularly true since the immunoglobulin nature of B-cell receptors 
is now  well established and  increasing sophistication in  the  knowledge of  antigen 
binding and movement of these receptors is being obtained (2). Since the threshold of 
tolerance induction in T  cells is considerably lower than it is in B cells (3, 4), at least 
insofar as protein antigens are concerned, it is difficult to obtain a  selective B-ceU 
tolerance in vivo to conventional T-cell-dependent antigens. 
In recent years, however, several investigators have reported the successful induc- 
tion of true hapten-specific tolerance in vivo, which may, indeed, reflect a  state of 
restricted B-cell tolerance. The most effective methods employed have the common 
feature of treating animals with haptenic determinants on molecules or substances that 
fail to stimulate T  cells, or do so very poorly. Thus, such tolerance has been induced 
by administration of (a) hapten on nonimmunogenic moieties such as the synthetic 
copolymers of D-glutamic acid and n-lysine (D-GL),  1 or ~GL in PLL nonresponder 
guinea pigs (5, 6) or inbred mice (7, 9), (b)haptenic derivatives  of autologousproteins 
(10-14), autologous or syngeneic red cells (15), or (c) polysaccharides such as type III 
pneumococcal polysaccharide (16,  17). We suggested earlier that a possible explana- 
tion for the ease of tolerance induction with the hapten conjugates of nonimmunogenic 
copolymers such as D-GL and also for other non- or weakly immunogenic substances 
may be the lack of the simultaneous occurrence of immunization and tolerance induc- 
tion  when  these  substances  are  administered in  appropriate conditions  (1,  5).  If, 
as we suggested, the weak immunogenicity of these tolerogens reflects the relative 
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1  Abbreviations used in this paper: BGG, bovine gamma globulin; CFA, complete Freund's 
adjuvant; D-GL, D-glutamic acid and D-lysine; DNP-KLH, DNP keyhole limpet hemocyanin; 
OVA, ovalbumin; PLL, poly-L-lysine. 
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lack of stimulation of specific helper T  ceils, then the prediction may be made that 
ease of tolerance induction by any molecule in B cells will show an inverse correlation 
with the degree of helper T-cell activity involved.  This  concept has been recently 
extended by Mitchell in an ingenius hypothesis concerning regulatory T-cell function 
in antibody responses (17). 
The present studies were designed to probe the role(s) of T cells in preventing 
or altering tolerance induction in hapten-specific B cells. This was accomplished 
by using hapten conjugates of normally immunogenic heterologous carriers  2 to 
selectively inhibit 2,4-dinitrophenyl (DNP)-primed B  cells in adoptive transfer 
experiments in vivo. The data provide strong indications that one critical role 
of helper T-cell participation in humoral responses to antigens is  to  circum- 
vent the development of a tolerogenic signal that, in the absence of such T-cell 
function,  might otherwise ensue after binding  of the  antigenic  determinants 
by specific precursor B lymphocytes. 
Materials and Methods 
The proteins, hapten-earrier conjugates, animals, immunization schedules, adoptive trans- 
fer system, antibody determinations, and statistical analyses were identical to those described 
in the preceding  paper (9). The following  additional DNP-protein conjugates were employed: 
DNPs-OVA and DNP32-BGG. 
Depletion o.f T Lymphocytes. The preparation of anti-0 serum, determination of anti-0 
serum cytotoxicity, and treatment of spleen cells  with anti-0 serum plus complement  has been 
detailed in previous studies from this laboratory  (18). 
RESULTS 
Induction  of  Tolerance in  Adoptively  Transferred  DNP-Specific  t~  Cells  by 
Nonimmunogenic  or  Unrelated  Immunogenic  DNP-Carrier  Conjugates.--We 
have previously shown that DNP-D-GL is a  highly effective tolerogenic mole- 
cule for primed or unprimed DNP-specific B  cells adoptively transferred into 
irradiated recipients (5,  7,  9). The following experiment was  designed to ask 
whether or not metabolizable in-lmunogenic  or nonimmunogenic DNP carriers 
could also serve as relatively effective tolerogens in similar conditions. For this 
purpose, we chose DNP-L-GL as a  metabolizable but nonimmunogenic mole- 
cule  (9)  and  DNP-OVA,  and  DNP-BGG  as  normally  immunogenic  DNP- 
protein conjugates. 
The protocol and data of this experiment are summarized in Fig.  1. Spleen 
cells  from  A/J  donor mice  primed  2  mo  earlier  with  DNP  keyhole limpet 
hemocyanin (DNP-KLH) in complete Freund's adjuvant (CFA)  were trans- 
ferred  intravenously  to  irradiated  (550  R)  syngeneic  recipients  (50  X  106 
cells/mouse). Immediately after transfer, groups of recipient mice were treated 
by  intraperitoneal  injection  of  200  #g  of  either  DNP-D-GL,  DNP-L-GL, 
DNP-BGG, or DNP-OVA. Controls received saline. 3 days later, all  recipients 
2  The term heterologous  carrier refers to any carrier molecule unrelated to that used for 
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FIo. 1.  Induction of tolerance in adoptively transferred DNP-specific B cells by exposure 
of such cells to nonimmunogenic or unrelated  immunogenic DNP-carrier  conjugates. The 
protocol is schematically depicted on the left of figure. Recipient groups were treated  with 
saline or one of the DNP conjugates as indicated below the data bars. Each group consists 
of six mice. Statistical comparison of antibody responses of recipient groups treated with the 
various DNP carrier conjugates before secondary challenge to those of saline control recipients 
yielded the P values of 0.001 >  P in all cases. 
were challenged intraperitoneally with  100/~g of DNP-KLH and then  bled 7 
days thereafter. As shown in Fig. 1, all recipients treated with one of the DNP 
carriers  employed were  considerably depressed  in  their  capacity  to  develop 
secondary responses to DNP-KLH as compared to saline-treated controls. Al- 
though clearly most marked in the case of DNP-D-GL  treatment, diminution 
of at least 90 %  or more was obtained as well as with the other molecules em- 
ployed. 
Partial Reversal of DNP-Specific  Tolerance Induced in  Vivo  With Immuno- 
genic DNP Proteins by Serial Adoptive Transfer.--In view of the relative facility 
with which DNP-specific B  cells could be rendered unresponsive by exposure 
to  heterologous  carrier  conjugates  in  the  preceding  experiment,  we  felt  it 
necessary  to  explore  the  relative  reversibility of  this  unresponsive state  as 
compared to that induced by the tolerogen DNP-D-GL. 
The protocol of this experiment is depicted schematically in Fig. 2. Spleen  cells from A/J 
donor mice primed 6 mo earlier with DNP-KLH in CFA were treated  in vitro with anti-0 
serum plus complement to remove T lymphocytes and then transferred intravenously to 550 
R irradiated  syngeneic recipients (20 X  106 cells/mouse). Groups of 10 recipients were then 
treated  by intraperitoneal  injection  of either  saline, DNP-KLH, DNP-D-GL, DNP-L-GL, 
DNP-BGG, or DNP-OVA. After an interval of 7 days the mice were bled, sacrifced and their 
spleen cells removed, pooled for respective groups, and thoroughly washed with Eagle's mini- 
mal essential medium. 15 X  106 of the respective pooled cells were then transferred intra- 
venously together with 50 X  106 spleen cells from syngeneic KLH-primed  (100 #g in CFA, 
1 mo earlier) donor mice to new individual irradiated syngeneic recipient mice. All of the new 
recipient groups were challenged with DNP-KLH and then bled 7 days thereafter. 
With the exception of the DNP-KLH-treated group, none of the groups of 
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FIG. 2.  Partial reversal of tolerance induced in vivo with immunogenic DNP proteins by 
serial adoptive transfer. The protocol is schematically depicted on the left of figure. Primary 
recipient groups were tested with saline or one of the DNP conjugates as indicated below the 
data bars. Each group consists of five mice. Relevant statistical comparisons of responses of 
the various recipient groups yielded the following P  values: (a) saline vs. DNP-KLH, 0.90 ~> 
P  ~> 0.80; (b) saline or DNP-KLH vs. DNP-D-GL or DNP-L-GL, 0.001 ~> P in every case; 
(c) saline or DNP-KLH vs. DNP-BGG, 0.40 ~  P  ~> 0.30; (d) saline or DNP-KLH vs. DNP- 
OVA, 0.10 ~> P  ~> 0.05; (e) DNP-BGG or DNP-OVA vs. DNP-D-GL  or DNP-L-GL, 0.001 ~> 
P in every case. 
sacrifice. The group treated with DNP-KLH developed small, but detectable, 
anti-DNP  responses  (average 21.3  /~g/ml)  probably reflecting a  combination 
of residual T  cells in the anti-0-treated cell population and the strong immuno- 
genicity of KLH as an inducer of helper T  cells.  As shown in Fig. 2, the second 
recipients  of  the  various  treated  cell  inocula  manifested  variable  responses 
depending on the nature of the treatment employed. Recipients of cells exposed 
to  either  saline  or  DNP-KLH  in  the  first  recipients  developed  very  good 
responses to DNP-KLH demonstrating the functional  integrity of the DNP- 
specific B cells as well as that of the fresh KLH-specific T cells from the carrier- 
primed donors. On the other hand, recipients of cells exposed to either DNP- 
D-GL  or  DNP-L-GL  failed  to  develop  secondary  anti-DNP  responses.  In 
contrast to the latter groups,  however, cells exposed to DNP-BGG or DNP- 
OVA  were partially recovered in  their  functional  responsiveness manifesting 
secondary  responses  that  were  66%  and  47 %,  respectively,  of  the  control 
groups. 
DISCUSSION 
The interaction  of B  lymphocytes with molecules bearing specific determi- 
nants either (a) provides one of the programmed stimuli for proliferation and 
differentiation into antibody-secreting cells,  or,  alternatively (b)  causes these 1468  TOLERANCE  IN  B  LYMPHOCYTES.  HI 
cells to become temporarily or permanently unresponsive. In addition  to the 
crucial  role of antigen  concentration  in  affecting these processes, the  studies 
described herein have emphasized the importance of helper T-cell activity in the 
determination  whether  immunity  or  unresponsiveness  will  ensue.  In  the 
absence of an appropriate and sufficient level of T-cell activation,  the inter- 
action  of B-cell receptors with antigens which,  in  the presence of T-cell par- 
ticipation,  would be sensed as an immunogenic stimulus renders  the cell un- 
responsive.  These  findings  imply  that  T-cell  helper  activity would  be more 
effective on B  cells when initiated  before rather than after B-cell interaction 
with the epitope, and also that a  B  cell which has interacted with a  thymus- 
dependent  antigen  is susceptible  to T-cell helper  effect for a  relatively short 
period of time. Both of these postulates have been verified experimentally.* 
In the absence of adequate helper T-cell activity, administration  of DNP- 
OVA or DNP-BGG to recipients of adoptively transferred DNP-KLH-primed 
cells  diminished  the  subsequent  secondary response  to DNP-KLH challenge 
carried out 3 days later by more than 90 %  (Fig.  1). This was true also in the 
case of administering DNP-D-GL or DNP-L-GL, but the conditions favorable 
to  tolerance  induction  by  these  molecules may be somewhat  different  from 
those  involved in  unresponsiveness induced  by DNP-conjugates  of normally 
immunogenic substances  such as OVA or BGG. Indeed,  this  is  quite  clearly 
suggested  by  the  substantial  recoveries  of  responses  observed when  B  cells 
exposed to DNP-OVA or DNP-BGG in first adoptive recipients were  subse- 
quently transferred to new recipients together with additional  carrier-primed 
cells.  In  contrast,  cells  exposed initially  to  either  DNP-D-GL or  DNP-L-GL 
failed to  display any appreciable recovery in  responsiveness under  the same 
circumstances (Fig. 2). 
In our initial studies on hapten-specific  tolerance in guinea pigs, we demonstrated 
that administration of the nonimmunogenic compound, DNP-D-GL induced profound 
DNP-specific tolerance in both strain 2 and strain 13 inbred guinea pigs (5). More- 
over, in the case of strain 13 guinea pigs,  which  are genetic nonresponders to L-GL 
(19),  a  comparable degree of DNP-specific tolerance was induced after administra- 
tion of DNP-~-GL; strain 2 responder guinea pigs, on the other hand, developed anti- 
DNP  antibody responses  to  the  latter  compound  (5).  Our  interpretation  of  these 
observations was that the ease of tolerance induction with such DNP conjugates of 
nonimmunogenic or weakly immunogenic substances reflects the lack of simultaneous 
occurrence of immunization and tolerance induction when these substances are ad- 
ministered. If, therefore, the weak immunogenicity of a substance is primarily deter- 
mined by (a) the absence or scarcity of effective helper T  cells specific for that sub- 
stance, and  (b)  the relative inability of the material to activate B cells without the 
functional cooperative influence of T cells, then tolerance induction by hapten conju- 
3 Katz, D. H., P. E. Newburger, T. Hamaoka, and B. Benacerraf. 1974. Hapten-specific 
IgE antibody responses in mice. IV. Evidence for distinctive sensitivities of IgE and IgG B 
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gates of such materials  may be interpreted to result from direct interaction,  in the 
appropriate  dose range,  with specific precursors  of antibody-forming  cells without 
intervening  helper  cells (5). Indeed, these predictions  appear  to have been  amply 
borne out by a number of models of hapten-specific tolerance in which the common 
feature of the tolerance-inducing molecules has been their relative inability to activate 
specific helper T cells (5-17). 
In the studies described in the preceding (7, 9) and present papers dealing 
with B-cell tolerance in mice, we have reaffirmed the potent tolerance-inducing 
properties of DNP-conjugates of the nonimmunogenic copolymers of D- and 
L-GL. The additional demonstration in the present studies of the capacity to 
interfere with secondary anti-DNP responses with DNP-OVA and DNP-BGG 
under  certain  circumstances  deserves  extended  comment.  These  conjugates 
are normally immunogenic in mice in a  variety of experimental systems. The 
carriers, OVA and BGG, are capable of stimulating specific T-cell helper func- 
tion in proper conditions of immunization so we know that functional T  cells 
specific  for their respective determinants do indeed, exist. How then can we 
explain  the  significant inhibitory effects obtained after  exposure  of  cells  to 
these  compounds under  certain  conditions? First,  it should be  recalled that 
we have been dealing in these experiments with primed B  cells,  presumably 
largely of moderate-to-high affinity receptor type since they were taken from 
donors primed quite some time earlier. Second, the conditions in which inhibi- 
tion by these substances was observed involved short-term exposure of cells to 
relatively high doses of the conjugates in aqueous form. The importance of 
this lies in the fact that these conditions are quite inefficient for inducing good 
helper T-cell function in a  population of unprimed (for that antigen) T  lym- 
phocytes within a  critical time period and may, indeed, for this reason cause 
some degree of tolerance induction in unprimed animals. Thus, where signifi- 
cant inhibition is best obtained, there exists a  combination of conditions that 
on the one hand favor relatively avid antigen binding by specific  B  lympho- 
cytes (i.e., primed and of high average affinity) and, on the other hand, tend 
to be unfavorable for induction of carrier-specific  helper T-cell function. 
In the context of the above reasoning, important questions are raised by the 
contrasting observations reported herein in which DNP-OVA and DNP-BGG 
were  essentially comparable  to  DNP-D-GL  and  DNP-L-GL  in  the  level  of 
tolerance induced in one experiment (Fig.  1)  but clearly different in another 
(Fig. 2). The probable explanation for these differences lies in the fact that in 
the  first  experiment  secondary  challenge  was  made  in  the  same  adoptive 
recipient that had been treated with the various tolerogenic compounds and, 
moreover, within a  much shorter time interval after exposure. In the second 
experiment, on the other hand, B cells were exposed to the various substances 
and then removed from the milieu of the  first recipient  to a  new recipient 
before being subjected to secondary challenge. In addition, in the latter case a 
longer interval (7  days)  was employed and, perhaps most important, a  new 1470  TOLERANCE  IN B  LYMPHOCYTES.  III 
and probably larger population  of carrier-primed helper T  cells was provided 
in  the  second  recipients.  It  is  difficult  to  ascertain  what  factors  were  most 
important in the partial recovery of responses observed with cells exposed to 
DNP-OVA or DNP-BGG; the longer time interval may have favored partial 
spontaneous  recovery of  a  subpopulation  of  the  B  cells,  and/or  the  poten- 
tiating  effect of  transferring  cells  not  yet  irreversibly  inactivated  to  a  new 
irradiated  recipient environment could account for  these  results.  In  the  pre- 
ceding paper (9),  it was clearly shown that the DNP-D-GL molecule induces 
an  irreversible state  of tolerance in  B  cells  which  can  be both  operationally 
and  morphologically  4  distinguished  from  the  unresponsiveness  induced  by 
DNP-L-GL or DNP-OVA. 
The differences observed between the animals treated with DNP-L-GL and 
those which  received DNP  conjugates  of heterologous immunogenic  carriers, 
such  as  DNP-OVA  or  DNP-BGG  that  showed  considerable  recovery of re- 
sponsiveness to DNP-KLH may be ascribed to the  fact that  L-GL does not 
induce  T-cell  immunity  in  the  mouse,  whereas  OVA  and  BGG  are  T-cell- 
dependent  antigens  for  which  specific helper  T  cells  are  naturally  found  in 
nonimmune animals. This number of T  cells specific for these carriers may have 
been sufficient to exert some protection against tolerance induction  by DNP- 
BGG or DNP-OVA. 
In other  experimental systems under  study in  our laboratory in  which  the 
immune responses are under control of histocompatibility-linked Ir  genes, the 
extraordinary sensitivity of B cells to the induction of tolerance in the absence 
of helper T  cells has been demonstrated. Thus, Kapp, Pierce, and Benacerraf 
have observed that  H-2 ~ and  H-2q  mice which  are  genetically nonresponsive 
to the  terpolymer of glutamic acid,  alanine,  and  tyrosine  (GAT),  but  which 
nevertheless can mount anti-GAT responses to a complex of GAT and methyl- 
ated  bovine  serum  albumin  (MBSA)  are  rendered  unresponsive  to  GAT- 
MBSA by very small doses of previously administered GAT# Similarly, Dorf, 
Katz, and Benacerraf have demonstrated that the DNP conjugate of GAT is 
very tolerogenic for DNP B cells of nonresponder mice, even when administered 
in adjuvants. 6 
The mechanism by which helper T  cells protect specific B  cells from toler- 
ance induction  or,  to put it differently, the  process by which  tolerance is in- 
duced  in  the  absence  of protective helper  T-cell function  is not  understood. 
Experiments  are  in  progress  with  the  various  systems  mentioned  above  to 
determine if in this type of B-cell tolerance, unresponsiveness results from the 
direct interaction of the tolerogen with specific B-cell receptors in the absence 
4 K. A. Ault, E. R. Unanue, D. H. Katz, and B. Benacerraf. Manuscript in preparation. 
s j. A. Kapp, C. W. Pierce, and B. Benacerraf. 1974. Genetic control of immune responses 
in  vitro. III. Tolerogenic properties of the  terpolymer GAT for spleen cells from nonre- 
sponder (H-2  ~ and H-2q) mice. Manuscript submitted for publication. 
6 M. E. Doff, D. H. Katz, and B. Benacerraf. Manuscript in preparation. DAVID H.  KATZ, TOSHIYUKI  HAMAOKA, BARUJ BENACERRAF  1471 
of a  preceding or concomitant T-cell activation,  or whether the participation 
of postulated specific suppressor T  cells are involved in this phenomenon (20). 
SUMMARY 
The present studies were designed to probe the role(s) of T  cells in prevent- 
ing or altering tolerance induction in hapten-specific B  cells. This was accom- 
plished  by  using  hapten  conjugates  of  normally  immunogenic  heterologous 
carriers  to  selectively  inhibit  2,4-dinitrophenyl  (DNP)-primed  B  cells  in 
adoptive  transfer  experiments  in  vivo.  The data  provide  strong  indications 
that one critical role of T-cell participation in humoral responses to antigens 
is to circumvent the development of a  tolerogenic signal  that, in the absence 
of such T-cell function, might otherwise ensue after binding  of the antigenic 
determinants by specific precursor B  lymphocytes. 
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